We are live on
!
Find out more
TS
Third Security Portfolio holdings
AUM
$241M
1-Year Est. Return
45.43%
This Fund
S&P 500
This Quarter
Est. Return
+33.42%
1 Year Est. Return
-45.43%
3 Year Est. Return
-28.24%
5 Year Est. Return
-58.7%
10 Year Est. Return
–
AUM
$849M
AUM Growth
+$179M
(+27%)
Cap. Flow
-$18.4M
Cap. Flow
% of AUM
-2.17%
Top 10 Holdings %
Top 10 Hldgs %
99.97%
Holding
12
New
–
Increased
1
Reduced
1
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Precigen
PGEN
|
+$36.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halozyme
HALO
|
+$54.5M |
| 2 |
Theriva Biologics
TOVX
|
+$256K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 90.15% |
| 2 | Energy | 6.54% |
| 3 | Consumer Staples | 3.28% |
| 4 | Materials | 0.03% |
Similar funds
KRC
A
AIA
FG
RFA
UIA
GCM
GMA
Third Security's Q2 2019 Portfolio in Review
As of Q2 2019, Third Security held 12 positions worth $849M, up 27% from $670M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Third Security's Q2 2019 filing shows 1 increased, 1 reduced and 1 closed positions. The largest sale was Halozyme, an estimated $54.5M.
By sector, the portfolio is most concentrated in Healthcare at 90% of assets, up from 88% a quarter earlier, followed by Energy and Consumer Staples.
- Third Security added most to Precigen in Q2 2019, an estimated $36.4M increase.
- Third Security's biggest Q2 2019 reduction was Halozyme, cutting an estimated $54.5M.
- Third Security fully exited Theriva Biologics in Q2 2019, selling an estimated $256K.
- Third Security's ten largest holdings make up 100% of its $849M portfolio in Q2 2019.
- Third Security opened 0 new positions and closed 1 in Q2 2019.
- Third Security's portfolio value rose 27% quarter-over-quarter to $849M.
Based on Third Security's 13F filing for Q2 2019, filed 9 Aug 2019.